She was discharged home on May 12, 2009, and accepted warfarin (2 · 5 mg per day) as maintenancetherapy.
患者于2009年5月12号出院,接受华法林(2.5 mg每日)的维持治疗。
2
The drug is also approved for use as maintenancetherapy for chronic hyperammonemia that results from NAGS deficiency.
同时还批准该药物作为NAGS缺乏所致慢性高氨血症的维持治疗药物。
3
The study is reportedly the first prospective study to assess risk factors related to bullous pemphigoid relapse after cessation of maintenancetherapy.